Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$20,762,135
+$4,787,570 QoQ
Shares Held
17,310
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#873
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. LLY ranks #1 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,762,135 | 17,310 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $15,974,565 | 17,368 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $18,306,100 | 17,034 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $13,275,437 | 17,399 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $13,254,348 | 17,003 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $14,064,421 | 17,029 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $12,798,216 | 16,578 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $16,707,942 | 18,859 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,357,039 | 19,171 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $15,191,224 | 19,527 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,911,096 | 18,718 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $10,925,224 | 20,340 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $9,954,569 | 21,226 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $7,343,006 | 21,382 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $14,973,831 | 40,930 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,330,424 | 16,485 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,331,313 | 16,443 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,132,613 | 21,415 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,260,802 | 22,666 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,989,293 | 21,594 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,910,350 | 21,394 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,702,959 | 19,821 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,770,703 | 22,333 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,364,494 | 22,730 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,999,753 | 24,362 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,271,156 | 23,581 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||